Biotech Stock Roundup: GSK’s Litigation Update, BIIB’s Drug Approval & Other Updates
ZacksGSK and Biogen (BIIB) are in the spotlight following litigation updates and drug approval, respectively.
GSK and Biogen (BIIB) are in the spotlight following litigation updates and drug approval, respectively.